Papers
19
Total Citations
2,571
H-Index
13
About
Steven C. Campbell is a leading urologic oncologist whose work has fundamentally shaped the management of kidney cancer, particularly through the advancement of nephron-sparing surgery. His research centers on optimizing surgical techniques to preserve renal function without compromising oncologic outcomes. Campbell’s landmark contribution is the 2009 "Guideline for Management of the Clinical T1 Renal Mass," a seminal work with nearly 1,840 citations that established evidence-based standards for treating small renal tumors. He has been a pivotal figure in comparing laparoscopic, robotic, and open partial nephrectomy, demonstrating long-term oncologic safety and functional benefits—his 2013 study on 10-year outcomes (171 citations) is a key reference. Campbell also explored the critical impact of warm ischemia time on renal atrophy (81 citations) and championed non-ischemic approaches to maximize kidney preservation. His work extends to advanced disease, including neoadjuvant sunitinib for inferior vena caval thrombus (41 citations). Through high-impact studies and guideline authorship, Campbell has shaped clinical practice worldwide, making him an authoritative voice in the surgical management of renal cell carcinoma.
Research Focus
Key Achievements
Top Papers
- 1Guideline for Management of the Clinical T1 Renal Mass1,839 citations · 2009
- 210-Year Oncologic Outcomes After Laparoscopic and Open Partial Nephrectomy171 citations · 2013
- 3
- 4
- 5
- 6
- 7A Nonischemic Approach to Partial Nephrectomy is Optimal46 citations · 2011
- 8Tumor Enucleation for Sporadic Localized Kidney Cancer: Pro and Con43 citations · 2015
- 9
- 10